List of Chapters/Sections(Table Of Content)
1 Gabapentin Market Overview
1.1 Product Overview and Scope of Gabapentin
1.2 Gabapentin Segment by Type
1.2.1 Global Gabapentin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Segment by Application
1.3.1 Global Gabapentin Sales Comparison by Application: (2021-2027)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Restless Legs Syndrome
1.3.5 Others
1.4 Global Gabapentin Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Revenue 2016-2027
1.4.2 Global Gabapentin Sales 2016-2027
1.4.3 Gabapentin Market Size by Region: 2016 Versus 2021 Versus 2027
2 Gabapentin Market Competition by Manufacturers
2.1 Global Gabapentin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gabapentin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gabapentin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gabapentin Manufacturing Sites, Area Served, Product Type
2.5 Gabapentin Market Competitive Situation and Trends
2.5.1 Gabapentin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gabapentin Players Market Share by Revenue
2.5.3 Global Gabapentin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gabapentin Retrospective Market Scenario by Region
3.1 Global Gabapentin Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Gabapentin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Gabapentin Market Facts & Figures by Country
3.3.1 North America Gabapentin Sales by Country
3.3.2 North America Gabapentin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gabapentin Market Facts & Figures by Country
3.4.1 Europe Gabapentin Sales by Country
3.4.2 Europe Gabapentin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gabapentin Market Facts & Figures by Region
3.5.1 Asia Pacific Gabapentin Sales by Region
3.5.2 Asia Pacific Gabapentin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gabapentin Market Facts & Figures by Country
3.6.1 Latin America Gabapentin Sales by Country
3.6.2 Latin America Gabapentin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gabapentin Market Facts & Figures by Country
3.7.1 Middle East and Africa Gabapentin Sales by Country
3.7.2 Middle East and Africa Gabapentin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Gabapentin Historic Market Analysis by Type
4.1 Global Gabapentin Sales Market Share by Type (2016-2021)
4.2 Global Gabapentin Revenue Market Share by Type (2016-2021)
4.3 Global Gabapentin Price by Type (2016-2021)
5 Global Gabapentin Historic Market Analysis by Application
5.1 Global Gabapentin Sales Market Share by Application (2016-2021)
5.2 Global Gabapentin Revenue Market Share by Application (2016-2021)
5.3 Global Gabapentin Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Gabapentin Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Assertio Therapeutics
6.2.1 Assertio Therapeutics Corporation Information
6.2.2 Assertio Therapeutics Description and Business Overview
6.2.3 Assertio Therapeutics Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Assertio Therapeutics Gabapentin Product Portfolio
6.2.5 Assertio Therapeutics Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 TEVA Gabapentin Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Gabapentin Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Arbor Pharma
6.5.1 Arbor Pharma Corporation Information
6.5.2 Arbor Pharma Description and Business Overview
6.5.3 Arbor Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Arbor Pharma Gabapentin Product Portfolio
6.5.5 Arbor Pharma Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Gabapentin Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Apotex Gabapentin Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sun Pharmaceutical Gabapentin Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Aurobindo Pharma Gabapentin Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Intas
6.10.1 Intas Corporation Information
6.10.2 Intas Description and Business Overview
6.10.3 Intas Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Intas Gabapentin Product Portfolio
6.10.5 Intas Recent Developments/Updates
6.11 Amneal
6.11.1 Amneal Corporation Information
6.11.2 Amneal Gabapentin Description and Business Overview
6.11.3 Amneal Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Amneal Gabapentin Product Portfolio
6.11.5 Amneal Recent Developments/Updates
6.12 Marksans Pharma
6.12.1 Marksans Pharma Corporation Information
6.12.2 Marksans Pharma Gabapentin Description and Business Overview
6.12.3 Marksans Pharma Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Marksans Pharma Gabapentin Product Portfolio
6.12.5 Marksans Pharma Recent Developments/Updates
6.13 Glenmark
6.13.1 Glenmark Corporation Information
6.13.2 Glenmark Gabapentin Description and Business Overview
6.13.3 Glenmark Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Glenmark Gabapentin Product Portfolio
6.13.5 Glenmark Recent Developments/Updates
6.14 Alkem
6.14.1 Alkem Corporation Information
6.14.2 Alkem Gabapentin Description and Business Overview
6.14.3 Alkem Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Alkem Gabapentin Product Portfolio
6.14.5 Alkem Recent Developments/Updates
6.15 Jiangsu Enhua
6.15.1 Jiangsu Enhua Corporation Information
6.15.2 Jiangsu Enhua Gabapentin Description and Business Overview
6.15.3 Jiangsu Enhua Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Jiangsu Enhua Gabapentin Product Portfolio
6.15.5 Jiangsu Enhua Recent Developments/Updates
6.16 Jiangsu Hengrui
6.16.1 Jiangsu Hengrui Corporation Information
6.16.2 Jiangsu Hengrui Gabapentin Description and Business Overview
6.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Jiangsu Hengrui Gabapentin Product Portfolio
6.16.5 Jiangsu Hengrui Recent Developments/Updates
6.17 Sailike
6.17.1 Sailike Corporation Information
6.17.2 Sailike Gabapentin Description and Business Overview
6.17.3 Sailike Gabapentin Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Sailike Gabapentin Product Portfolio
6.17.5 Sailike Recent Developments/Updates
7 Gabapentin Manufacturing Cost Analysis
7.1 Gabapentin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gabapentin
7.4 Gabapentin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gabapentin Distributors List
8.3 Gabapentin Customers
9 Gabapentin Market Dynamics
9.1 Gabapentin Industry Trends
9.2 Gabapentin Growth Drivers
9.3 Gabapentin Market Challenges
9.4 Gabapentin Market Restraints
10 Global Market Forecast
10.1 Gabapentin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gabapentin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gabapentin by Type (2022-2027)
10.2 Gabapentin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gabapentin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gabapentin by Application (2022-2027)
10.3 Gabapentin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gabapentin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gabapentin by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
